Can cannabis trigger recurrent panic attacks in susceptible patients?

European Psychiatry

Volumn 12, Issue 8, 1997, Pages 415-419

  Langs, G ^a   Fabisch, H ^a   Fabisch, K ^a   Zapotoczky, H G ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cannabis; Depression; Panic attacks; Panic disorder

Indexed keywords

AMITRIPTYLINE; CANNABIS; CITALOPRAM;

ADULT; ANXIETY NEUROSIS; ARTICLE; CANNABIS ADDICTION; CASE REPORT; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; GRAND MAL SEIZURE; HUMAN; MALE; PANIC; PRIORITY JOURNAL;

EID: 0031472550     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)83568-7     Document Type: Article

References (38)

1. Adamec RE, Stark-Adamec C. Limbic kindling and animal behavior-implications for human psychopathology associated with complex partial seizures. Bio Psychiat 1983;18:269-93
2. Adams IB, Martin RM. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996;91(11):1585-614
3. Castle JD, Ames FR. Cannabis and the brain. Aust-N-Z-J Psychiatry 1996;30:179-83
4. Dantendorfer K, Amering M, Baischer W, Berger P, Steinberger K, Windhaber J, Katschnig K. Is there a pathophysiological and therapeutic link between panic disorder and epilepsy? Acta Psychiat Scan 1995a;91:430-2
5. Dantendorfer K, Windhaber J, Maierhofer D. Jackson seizure and panic disorder relieved by carbamazepine. Eur Psychiatry 1995b;10:370-1
6. Ellenhorn MJ, Barceloux DD. Medical Toxicology. Amsterdam: Elsevier, 1988
7. Goddard AW, Charney DS. Toward an integrated neurobiology of panic disorder. J Clin Psychiatry 1997;58(suppl 2):4-11
8. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Exptl Neurology 1969;25:295-330
9. German JM, Fyer MR, Liebowitz MR, Klein DF. Pharmacologic provocation of panic attacks. In: Meltzer HY, ed. Psychopharmacology: A third generation of Progress. New York: Raven Press, 1987;985-98
10. Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. Am J Psychiatry 1989; 146:148-61
11. Gouzolis E, Borchardt D, Hermle L. A Case of toxic psychosis induced by "EVE" (3,4-Methylene-dioxyethylam-phetamine). Arch Gen Psychiatry 1993;50-75
12. Guttmacher LB, Murphy DL, Insel TR. Pharmacologic models of anxiety. Comp Psychiatry, 1983;24:312-26
13. Halikas J. Marijuana use and psychiatric illness. In: Miller LE, ed. Marijuana: effects on human behavior. New York: Academic Press, 1974;265-302
14. Hemmeter U, Holsboer-Trachsler E. Neuroendokrinologie und Biochemie bei Angsterkrankungen. In: Kasper S, Möller HJ, eds. Angst- und Panikerkrankungen. Stuttgart, Jena: G Fischer, 1995;179-201
15. Heimle L, Spitzer M, Borchardt D, Gouzolis E. Beziehungen der Modell-bzw. Drogenpsychosen zu schizophrenen Erkrankungen. Fortschr Neurol Psychiat 1992;60:383-92
16. Hollister LE. Cannabis-1988. Acta Psychiatr Scan 1988; 78(suppl 345): 108-18
17. 9 trans-tetrahydrocannabinol in man. Psychopharmacologia 1967;11:184-8
18. Jaffe JJ. Psychoactive substance use disorders. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry, vol 1. Baltimore: Williams & Williams, 1989;642-98
19. Klein DF. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 1964;5:397-408
20. McCann UD, Ricaurte GA. MDMA ("Ecstasy") and panic disorder: induction by a single dose. Biol Psychiatry 1992;32:950-3
21. Margraf J, Schneider S. Angstanfälle und ihre Behandlung. Berlin, Heidelberg: Springer Verlag, 1989
22. Meyer R. Behavioral pharmacology of marijuana. In: Lipton MA, DiMascio A, Killam KF, eds. Psychopharmacology: a generation of progress. New York: Raven Press, 1978;1639-52
23. Moran C. Depersonalisation and agoraphobia associated with marijuana use. Br J Med Psychol 1986;58:187-96
24. 9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin Pharmacol Ther 1980;28: 409-16
25. Onaivi ES, Chakrabarti A, Chaudhuri G. Cannabinoid receptor genes. Prog Neurobiol 1996;48:275-305
26. Pertwee RG. The central neuropharmacology of psychotropic cannabinoids. Pharmacol Ther 1988;36:189-261
27. Rosenberg R. Kindling and panic disorder. In: Bolwig TM, Trimble MR, eds. The clinical relevance of kindling. New York: Wiley and Sons, 1989;263-73
28. Roth M, Harper M. Temporal lobe epilepsy and the phobic-anxiety depersonalisation syndrome, part I and II. Compr Psychiatry 1962;3:129-51,215-26
29. Roy-Byrne PP, Uhde T. Exogenous factors in panic disorder: clinical and research implications. J Clin Psychiatry 1988;49:56-61
30. Salkovskis PM, Clark DM. Cognitive and physiological processes in the maintenance and treatment of panic attacks. In: Hand I, Wittchen HU, eds. Panic and Phobias. Berlin, Heidelberg, New York: Springer, 1986;90-103
31. Seibyl JP, Crystal JH, Charney DS. Marijuana (cannabis) use is anecdotally said to precipitate anxiety symptoms in patients with panic disorder. Is there any research evidence to support this? Also, can Marijuana use precipitate or expose paranoia in patients with an underlying bipolar disorder? J Clin Psychopharmacol 1990;10:78
32. Sheehan DV, Sheehan KH. The classification of anxiety and hysterical states: II. Toward a more heuristic classification. J Clin Psychopharmacol 1982;2(6):386-93
33. Sieghart W. Transmittersysteme und Rezeptoren in der Neurobiologie der Angst. In: Kasper S, Möller HJ, eds. Angst- und Panikerkrankungen. Jena, Stuttgart: G Fischer Verlag 1995;202-20
34. Spitz MC. Panic disorder in seizure patients: a diagnostic pitfall. Epilepsia 1991;32(1):33-8
35. Strian F, Ploog D. Anxiety related to central nervous system dysfunction. In: Noyes R, Roth M, Burrows GD, eds. Handbook of anxiety, vol 2. Amsterdam: Elsevier, 1988;432-75
36. Thomas H. Psychiatric symptoms in cannabis users. Br J Psychiatry 1993;163:l41-9
37. Thomas H. A community survey of adverse effects of cannabis use. Drug Alcohol Dep 1996;42:201-7
38. Weilburg JB, Bear DM, Sachs G. Three patients with concomitant panic attacks and seizure disorder: possible clues to the neurology of anxiety. Am J Psychiatry 1987;144(8): 1053-6